Articles

Study: Health reform would be drag on Indiana economy

If one of the more liberal health care reform proposals becomes law, Hoosier taxpayers would have to spend $425 more per
person every year for the next decade, according to a study released Aug. 4 by Florida-based conservative policy group Arduin
Laffer & Moore Econometrics.

Read More

For Zotec CEO, health care reform cuts both ways

In the eyes of Scott Law, Congress is heading in exactly the wrong direction on health care reform.

But the
CEO of Zotec Partners predicts a big bump in sales for his physician-billing management company if current reform proposals
become law.

Read More

Lilly offering buyouts to 4,000 sales reps

Indianapolis-based Eli Lilly and Co. today said it is offering buyouts to its U.S. sales force,
with hopes of trimming about 300 sales representatives before a sales restructuring set to begin in January, Reuters reported.

Read More

Dow Chemical seems poised to keep AgroSciences

Midland, Mich.-based Dow Chemical Co. is still considering divesting Indianapolis subsidiary Dow AgroSciences LLC. But
chances that the chemical manufacturing giant will sell its local agricultural chemical and biotech unit appear to have decreased.

Read More

Is Indiana coming out of venture capital swoon?

Carmel-based Dormir LLC’s announcement July 29 of $12 million in venture financing was the second local life sciences
deal announced in July. It could suggest a turnaround from a woeful second-quarter performance, when Indiana life
sciences firms announced zero venture capital deals.

Read More

Lilly’s Effient launch just one of its many challenges

Eli Lilly and Co. has blasted past analysts’ earnings projections for two straight quarters. But if Lilly officials
take that as a sign they can breathe easier, they need only flip through a stack of Wall Street research reports on the company.

Read More

Dow Agro sale still possible, but less likely

Midland, Mich.-based Dow Chemical Co. is still considering divesting Indianapolis subsidiary Dow AgroSciences LLC. But chances
that the chemical manufacturing giant will sell its local agricultural chemical and biotech unit have decreased.

Read More

Carmel’s Dormir raises $12M from venture capital firms

Carmel-based Dormir Inc., which operates sleep study centers and sleep equipment stores around the country, raised $12 million
in venture capital from three out-of-state firms. The company plans use the proceeds to acquire six to 10 companies this year
and more next year, according to CEO Tim Miller.

Read More

Dow AgroSciences names new CEO

Indianapolis-based Dow AgroSciences LLC will have a new CEO after its parent organization moves Jerome Peribere into a new
position, the company announced today. Antonio Galindez, 54, vice president of Dow AgroSciences’ crops business, will step
into the top job.

Read More

A new centerpiece for city’s convention strategy: medical, science groups

The Indianapolis Convention and Visitors Association is putting together an all-star corporate consortium to make the city
a hub for medical and life sciences conventions, meetings and trade shows. The ICVA began running the initiative
full-speed this year and already has signed deals to bring 40 medical meetings to Indianapolis through 2015, including annual
meetings for the American Association of Diabetes Educators in 2012 and the American College of Sports Medicine and American
Chemical Society in 2013.

Read More

Conseco says profit in line with estimates

Conseco Inc. said it would meet analysts’ expectations for the second quarter by posting earnings of at least 22 cents
per share, before investment losses. The Carmel-based health insurer announced the preliminary financial results today after
the market closed.

Read More